Compile Data Set for Download or QSAR
Report error Found 269 Enz. Inhib. hit(s) with all data for entry = 12622
Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715459(US20250026765, Compound I-065)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715460(US20250026765, Compound I-066)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715458(US20250026765, Compound I-064)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715466(US20250026765, Compound I-073)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715464(US20250026765, Compound I-071)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715465(US20250026765, Compound I-072)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715462(US20250026765, Compound I-069)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715463(US20250026765, Compound I-070)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715384(US20250026765, Compound I-067)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715461(US20250026765, Compound I-068)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715440(US20250026765, Compound I-044)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715437(US20250026765, Compound I-041)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715435(US20250026765, Compound I-039)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715448(US20250026765, Compound I-053)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715445(US20250026765, Compound I-050)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715443(US20250026765, Compound I-047)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715444(US20250026765, Compound I-048)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715490(US20250026765, Compound I-101)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715487(US20250026765, Compound I-097)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715497(US20250026765, Compound I-110)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715498(US20250026765, Compound I-111)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715495(US20250026765, Compound I-108)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715496(US20250026765, Compound I-109)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715493(US20250026765, Compound I-106)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715494(US20250026765, Compound I-107)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715491(US20250026765, Compound I-102)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715492(US20250026765, Compound I-103)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715474(US20250026765, Compound I-082)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715472(US20250026765, Compound I-079)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715385(US20250026765, Compound I-080)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715470(US20250026765, Compound I-077)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715482(US20250026765, Compound I-092)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715480(US20250026765, Compound I-090)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715477(US20250026765, Compound I-085)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715478(US20250026765, Compound I-086)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715475(US20250026765, Compound I-083)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715476(US20250026765, Compound I-084)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715515(US20250026765, Compound I-134)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715408(US20250026765, Compound I-009)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715409(US20250026765, Compound I-010)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715406(US20250026765, Compound I-007)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Shionogi

US Patent
LigandPNGBDBM715404(US20250026765, Compound I-004)
Affinity DataKi: <10nMAssay Description:Radioactive ligand: [3H]-Ketanserin with a final concentration of around Kd value calculated by the following method[1046]Non-specific ligand: Seroto...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715506(US20250026765, Compound I-122)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715503(US20250026765, Compound I-119)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715499(US20250026765, Compound I-112)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715500(US20250026765, Compound I-116)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715513(US20250026765, Compound I-132)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715514(US20250026765, Compound I-133)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715511(US20250026765, Compound I-129)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Shionogi

US Patent
LigandPNGBDBM715512(US20250026765, Compound I-131)
Affinity DataKi: <10nMAssay Description:In advance, 0.5 μL of the compound solution dissolved in DMSO is dispensed into a microplate, and the cell membrane and the hot ligand are diluted wi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent

Displayed 1 to 50 (of 269 total ) | Next | Last >>
Jump to: